Profile
John M.
Sorvillo formerly worked at Bionaut Pharmaceuticals, Inc., as Chief Executive Officer from 2005 to 2006, ReForm Biologics LLC, as Chief Executive Officer & Director from 2017 to 2021, Paloma Pharmaceuticals, Inc., as Director, OSI Pharmaceuticals, Inc., as Vice President & GM-Research Products Division, ArQule, Inc., as Vice President-Business Development from 1995 to 2005, Genocea Biosciences, Inc., as Vice President-Business Development, and Altus Pharmaceuticals, Inc., as Vice President-Business Development from 2006 to 2009.
Dr. Sorvillo received his undergraduate degree from Hunter College and doctorate degree from New York University.
Former positions of John M. Sorvillo
| Companies | Position | End |
|---|---|---|
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Chief Executive Officer | 2021-09-07 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 2009-03-26 |
Bionaut Pharmaceuticals, Inc.
 Bionaut Pharmaceuticals, Inc. BiotechnologyHealth Technology Bionaut Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. It is a Biotechnology company using its technology to discover and advance novel small molecule drug candidates that affect well-validated disease pathways. Bionaut's business strategy is to license its candidates at a late preclinical stage to pharmaceutical and large biotech companies for development. The company was founded in August, 2000 by Mehran M. Khodadoust & Thomas Klein and is headquartered at Cambridge, MA. | President | 2006-07-31 |
| ARQULE, INC. | Director/Board Member | 2004-12-31 |
Paloma Pharmaceuticals, Inc.
 Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Director/Board Member | - |
Training of John M. Sorvillo
| Hunter College | Undergraduate Degree |
| New York University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Paloma Pharmaceuticals, Inc.
Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Bionaut Pharmaceuticals, Inc.
Bionaut Pharmaceuticals, Inc. BiotechnologyHealth Technology Bionaut Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. It is a Biotechnology company using its technology to discover and advance novel small molecule drug candidates that affect well-validated disease pathways. Bionaut's business strategy is to license its candidates at a late preclinical stage to pharmaceutical and large biotech companies for development. The company was founded in August, 2000 by Mehran M. Khodadoust & Thomas Klein and is headquartered at Cambridge, MA. | Health Technology |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John M. Sorvillo
